{
    "Trade/Device Name(s)": [
        "NEPHROCHECK Test System"
    ],
    "Submitter Information": "Astute Medical, Inc.",
    "510(k) Number": "K171482",
    "Predicate Device Reference 510(k) Number(s)": [
        "K153165"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PIG"
    ],
    "Summary Letter Date": "October 10, 2017",
    "Summary Letter Received Date": "October 10, 2017",
    "Submission Date": "October 10, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1220"
    ],
    "Regulation Name(s)": [
        "Acute kidney injury test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "TIMP-2",
        "IGFBP-7"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ASTUTE 140 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Kit",
        "Analyzer",
        "Cartridge",
        "Control",
        "Calibration Verification"
    ],
    "Document Summary": "FDA 510(k) summary for modified NEPHROCHECK Test System for risk assessment of acute kidney injury using urine immunoassay detection of TIMP-2 and IGFBP-7.",
    "Indications for Use Summary": "Intended for use in ICU patients (age 21+) with current or recent (past 24 hours) acute cardiovascular and/or respiratory compromise, as an aid for assessing risk of moderate or severe acute kidney injury within 12 hours of assessment, in conjunction with clinical evaluation.",
    "fda_folder": "Clinical Chemistry"
}